张军 教授
硕士招生类型：学术型
硕士招生专业：基础医学
博士招生类型：学术型
博士招生专业：基础医学
所在院系：医学院
联系方式：junzhang@tongji.edu.cn
课题组链接：
研究方向
主要任职
科研业绩

1.干细胞分化与表观遗传学机制研究Stem cell differentiation and epigenetic mechanisms；
2.干细胞在转化医学及再生医学中的应用研究Research on the application of stem cells in translational medicine and regenerative medicine；
3.肿瘤表观遗传学调控机制研究The mechanism of tumor epigenetic regulation
同济大学医学院教授，博导，现任同济大学医学院党委书记、同济大学转化医学高等研究院常务副院长。
中华医学会细胞生物学分会委员，上海市细胞学会监事，中国医药生物技术协会转化医学分会常务理事，中国转化医学联盟常务理事。
Jun Zhang is the professor of Tongji University School of Medicine and a doctoral supervisor. He is now the secretary of the party committee of Tongji University School of Medicine，the executive vice President of the institute of translational medicine of tongji university, and member of cell biology branch of Chinese medical association, supervisor of Shanghai cell society, executive director of translational medicine branch of China medical biotechnology association, and executive director of China translational medicine alliance.
长期从事干细胞再生医学与转化医学研究工作，主要研究方向集中为间充质干细胞和神经干细胞定向分化，以及干细胞临床转化与再生医学等领域。尤其在非编码RNA调控干细胞定向分化方面，阐明了相关miRNA分子对神经干细胞向神经元或神经胶质细胞分化过程中命运决定的分子机制。目前正在进行脂肪间充质干细胞临床前及相关临床研究工作，进一步开展了干细胞临床转化与应用，并已获初步成效。近5年来，带领的科研团队主持及承担科技部重大项目、国家自然科学基金项目及国际合作项目等10余项，发表论文50余篇，其中在Cell, Cur Mol Medcine, Nanoscare等杂志发表SCI论文近20篇。
Pro. Zhang is engaged in researches on the stem cell regenerative medicine and translational medicine, especially the specific differentiation of mesenchymal stem cells and neural stem cells. In particular, his team elucidates the molecular mechanism of miRNAs that determines the fate of neural stem cells in the differentiation into neurons or glial cells. At present, preclinical and related clinical studies on ADSC are being carried out in his team and preliminary results have been obtained. In recent 5 years, Pro. Zhang team has presided over and/or participated in more than ten projects including the Major Projects of the Ministry of Science and Technology, NSFC (Natural Science Foundation of China), and international cooperation projects. His team has published more than 50 papers including 17 SCI papers, such as Cell, Cur Mol Medcine, Nanoscare, Biochem j. and so on.